Nostics Welcomes Medtech Visionary Jeroen Nieuwenhuis as New CEO

Exciting News from Amsterdam: Nostics Welcomes Seasoned Medtech Innovator, Jeroen Nieuwenhuis, as CEO

Amsterdam, September 19, 2023 – Nostics, a groundbreaking medical diagnostics startup, is proud to announce the appointment of Jeroen Nieuwenhuis, a distinguished medtech entrepreneur, as its new Chief Executive Officer. Jeroen’s arrival heralds a significant milestone in Nostics’ journey as it gears up to introduce its revolutionary diagnostics technology to the point-of-care market.

Nostics is at the forefront of medical innovation with its versatile diagnostic platform that fuses Raman spectroscopy, nanotechnology, and AI-based classification. This cutting-edge technology is tailored for rapid infectious disease diagnostics, with a primary focus on combatting antibiotic resistance by guiding more effective antibiotic treatment. Nostics is dedicated to enhancing accessibility, accuracy, and affordability in diagnostics, especially in primary care facilities, labs, and hospitals.

Jeroen Nieuwenhuis brings a wealth of experience to the Nostics team, boasting a remarkable career in in-vitro diagnostics spanning over 15 years. His expertise, particularly in point-of-care diagnostics, is unparalleled. Having held diverse roles in R&D, strategy, and business development, he successfully oversaw the spinout of the Minicare technology from Philips, enabling rapid point-of-care heart attack diagnosis. Under his guidance, a second-generation product was developed and later acquired by Siemens Healthineers.

Taking the reins at Nostics, Jeroen envisions a future where the company’s technology evolves into a robust diagnostics platform, capable of addressing various infectious disease needs. He aspires to create a platform that not only tackles current challenges but also adapts to potential emerging threats.

Reflecting on his new role, Jeroen shares his enthusiasm: “Armed with a promising technology and a passionate team, I am excited to embark on the journey to take Nostics’ platform from the lab to the market.”

Jeroen joins the management team alongside co-founders Eva Rennen, Rochelle Niemeijer, and Vincent Laban, along with Bob de Vos (Lead AI). Vincent (former CEO, now CFO) expresses his delight, stating, “I am extremely pleased to welcome Jeroen as our new CEO. The success of Minicare over the last years has been inspiring. We strive to create similar breakthroughs in infectious disease diagnostics, and Jeroen’s background makes him the ideal candidate to lead Nostics through the next phase.

About Nostics:

Nostics, the cutting-edge medical diagnostics startup, emerged in 2020 with a bold vision. This innovative company is on a mission to revolutionize the world of diagnostics by providing instant, affordable, and easily accessible solutions for bacterial infections and other pathogens. How do they do it? By seamlessly combining the power of Raman spectroscopy, nanotechnology, and AI-driven pathogen classification into a portable point-of-care device.

Nostics isn’t just transforming diagnostics; it’s saving lives, combating antimicrobial resistance, and breaking down barriers to healthcare access for millions. Traditional labs can be out of reach for some, either due to location or cost. With Nostics, efficient patient treatment becomes a reality, making healthcare more equitable and effective. Welcome to the future of diagnostics with Nostics!

Leave a Comment